Valuation: Renascience Inc.

Market Cap 1.41TCr 8.89Cr 7.93Cr 7.4Cr 6.73Cr 13Cr 861.58Cr 13Cr 88Cr 35Cr 439.02Cr 33Cr 33Cr P/E 2025
118x
P/E 2026 -71.8x
Enterprise Value 1.07TCr 6.74Cr 6.01Cr 5.61Cr 5.1Cr 9.59Cr 653Cr 9.69Cr 67Cr 26Cr 332.73Cr 25Cr 25Cr EV / Sales 2025
87.3x
EV / Sales 2026 290x
Free-Float
43.01%
Yield 2025 *
-
Yield 2026 -
1 day-2.95%
1 week-12.89%
Current month-12.89%
1 month-14.36%
3 months-29.46%
6 months-33.46%
Current year-27.97%
1 week 1,015
Extreme 1015
1,127
1 month 1,015
Extreme 1015
1,313
Current year 1,015
Extreme 1015
2,185
1 year 1,015
Extreme 1015
2,320
3 years 263
Extreme 263
3,310
5 years 263
Extreme 263
3,310
10 years 263
Extreme 263
3,310
Manager TitleAgeSince
President 65 01/06/2025
Chief Tech/Sci/R&D Officer - -
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 65 01/04/2020
Director/Board Member 67 01/06/2024
Director/Board Member 63 01/06/2025
Change 5-day change 1-year change 3-year change Capi.($)
-2.95%-12.89%-49.85%+103.59% 9.16Cr
-1.61%+1.08%+38.64%+106.93% 1,06000Cr
-0.76%-3.12%+35.78%+62.70% 62TCr
+0.39%+4.14%+17.00%+83.77% 48TCr
-0.29%-2.02%+62.52%+37.06% 35TCr
-2.03%+1.03%+22.25%+42.16% 35TCr
-1.92%-1.87%+11.94%+33.20% 27TCr
-2.36%-3.16%-6.95%+8.68% 25TCr
-1.37%-3.34%+37.86%+52.33% 22TCr
+0.17%-1.31%+25.96%+96.82% 18TCr
Average -1.48%-1.46%+19.52%+62.72% 37.88TCr
Weighted average by Cap. -0.95%+0.04%+30.57%+68.82%

Financials

2025 2026
Net sales 13Cr 8L 7L 7L 6L 11.88L 8.09Cr 12.01L 82.75L 32.56L 4.12Cr 31.37L 30.7L 6.8Cr 4L 4L 4L 3L 6L 4.17Cr 6L 42.63L 16.78L 2.12Cr 16.16L 15.82L
Net income 11Cr 7L 6L 6L 5L 10.17L 6.93Cr 10.28L 70.84L 27.88L 3.53Cr 26.86L 26.28L -30Cr -19.05L -16.99L -15.84L -14.41L -27.09L -18Cr -27.38L -1.89Cr -74.26L -9.4Cr -71.54L -70.01L
Net Debt -179.9Cr -1.14Cr -1.02Cr -94.68L -86.1L -1.62Cr -110.3Cr -1.64Cr -11Cr -4.44Cr -56Cr -4.28Cr -4.18Cr -340.2Cr -2.15Cr -1.92Cr -1.79Cr -1.63Cr -3.06Cr -208.58Cr -3.1Cr -21Cr -8.39Cr -106.28Cr -8.09Cr -7.91Cr
Projected Income Statement - Annual - Renascience Inc.
Logo Renascience Inc.
Renascience Inc is mainly engaged in the development and sale of pharmaceuticals and medical devices. The company is engaged in the research and development of various modalities (pharmaceuticals, medical devices, artificial intelligence (AI) solutions) to solve problems in the medical field, in collaboration with physicians. The Company is engaged in the development of drugs for four non-infectious aging-related diseases: cancer, diabetes, respiratory diseases, and cardiovascular diseases. The Company is also engaged in the solve of other medical issues such as diseases of women and children, and COVID-19 infection.
Employees
-
Date Price Change Volume
08/26/08 JP¥1,020.00 -2.95% 2,21,400
07/26/07 JP¥1,051.00 -3.67% 3,73,900
06/26/06 JP¥1,091.00 -0.73% 1,55,900
05/26/05 JP¥1,099.00 -0.36% 2,10,700
02/26/02 JP¥1,103.00 -2.39% 2,10,000

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Renascience Inc.
  1. Stock Market
  2. Stocks
  3. 4889 Stock